University of California, Irvine at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
University of California, Irvine brings 17 presentations to IDWeek 2026 in Washington. Its program centres on antimicrobial resistance and infection prevention, from drug-resistant Gram-negative bacteria to multidrug-resistant organisms in nursing homes. Distinctive work uses large language models to judge whether hospital-onset bloodstream infections could have been prevented and asks how sharing a nursing home room affects resistant organism carriage.
| Organization | IDWeek 2026 Attendance |
|---|---|
University of California, Irvine Irvine, CA | |
Talk Tue Oct 20 3:35pm–4:10pm Infection Control/Prevention Infection prevention and healthcare epidemiology Session Wed Oct 21 1:30pm–3:15pm Mano-a-Mano HIV, sexually transmitted infections and viral hepatitis Poster Thu Oct 22 12:15pm–1:30pm Assessing Signs, Symptoms, and Preventability of Hospital-Onset Bacteremia and Fungemia Using Large Language Models Poster Thu Oct 22 12:15pm–1:30pm Emerging Extended-Spectrum β-Lactamases (CMY in E. coli, PER in K. pneumoniae) Plus PBP3 Alterations Drive Aztreonam-Avibactam Resistance in Metallo-β-Lactamase-Producing Enterobacterales via Species-Specific Pathways Poster Thu Oct 22 12:15pm–1:30pm Impact of Being Roommates on Multidrug-Resistant Organism (MDRO) Carriage in Nursing Homes (NHs) Along with Mitigating and Exacerbating Factors for Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococci (VRE), and Extended-Spectrum Beta-Lactamase Producers (ESBL) Poster Thu Oct 22 12:15pm–1:30pm Inhibiting Multiple Penicillin-Binding-Proteins with Novel β-lactam Combinations is a Clinically Viable Therapeutic Strategy to Overcome Aztreonam-Avibactam and Cefiderocol Resistance in Metallo-β-lactamase Producing Enterobacterales Session Thu Oct 22 1:45pm–3:00pm Join the Resistance 101: Multitarget Therapies for XDR Gram-Negatives Antimicrobials, resistance and stewardship Talk Thu Oct 22 4:15pm–4:30pm Does Living in a Ventilator Capable Skilled Nursing Facility (vSNF) Put Non Ventilator Residents at Higher Risk for Candidozyma auris and Other Multidrug-Resistant Organisms (MDROs), Including Methicillin-Resistant Staphylococcus aureus (MRSA), Extended Spectrum beta-lactamase producers (ESBL), Vancomycin-Resistant Enterococci (VRE), Carbapenem-Resistant Acinetobacter baumannii (CRAB), and Carbapenem-Resistant Enterobacterales (CRE)? Infection prevention and healthcare epidemiologyAntimicrobials, resistance and stewardship Session Fri Oct 23 8:00am–9:00am No Time to Lose: Frontiers to Address Antimicrobial Resistance Antimicrobials, resistance and stewardship Session Fri Oct 23 10:30am–11:45am Join the Resistance 102: Connecting the Dots Between In Vitro, In Vivo & Clinical Outcomes Transplant and immunocompromised hostsAntimicrobials, resistance and stewardship Poster Fri Oct 23 12:15pm–1:30pm Effectiveness and Safety of Standard- vs Extended-spectrum Antibiotics for Empiric Therapy of Non-critically Ill Patients Hospitalized for Pneumonia, Urinary Tract Infection (UTI), Skin/Soft Tissue Infection (SSTI), and Abdominal Infection with and without Multidrug-Resistant Organisms (MDROs) Poster Fri Oct 23 12:15pm–1:30pm Impact of Vancomycin Restriction on Overall Vancomycin Days of Therapy at an Academic Medical Center Session Fri Oct 23 3:15pm–4:30pm Artificial Intelligence in ID: Rethinking Diagnostics, Therapy and Prevention Diagnostics and diagnostic stewardshipAntimicrobials, resistance and stewardship Talk Sat Oct 24 10:30am–10:45am Durability and Generalizability of Reductions in Extended-Spectrum Antibiotic Use After Trial Completion and Health-System Wide Adoption of the INSPIRE Trial Prompts for Pneumonia, Urinary Tract Infection (UTI), Skin/Soft Tissue Infection (SSTI), and Abdominal Infections. Antimicrobials, resistance and stewardship Session Sat Oct 24 10:30am–11:45am Join the Resistance 103: Drugging Undruggable Gram-Positive Bacteria Global and public healthTransplant and immunocompromised hostsAntimicrobials, resistance and stewardship Talk Sat Oct 24 11:20am–11:45am Molecular Mechanism Guided Combination Therapy Against MRSA and Enterococci Global and public healthTransplant and immunocompromised hostsAntimicrobials, resistance and stewardship Session Sat Oct 24 3:15pm–4:30pm Upcoming Therapeutics and Diagnostics, Integrated Solutions for Infectious Threats Transplant and immunocompromised hostsAntimicrobials, resistance and stewardshipDiagnostics and diagnostic stewardship |
Instantly find 20 buyers from University of California, Irvine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction